Lutronic USA LLC Earns US FDA Clearance for MOSAIC Fractional Laser System

Lutronic USA today announced that its MOSAIC fractional laser system has received US FDA 510(k) clearance for dermatological procedures requiring the coagulation of soft tissue.

Princeton Junction, NJ (PRWEB) July 27, 2007 -- Lutronic USA today announced that its MOSAIC fractional laser system has received US FDA 510(k) clearance for dermatological procedures requiring the coagulation of soft tissue. MOSAIC is an advanced aesthetic solution based on the latest in micro fractional technology that offers physicians an unprecedented combination of flexibility, precision and control for indications including scarring, sun-damaged skin and malasma.

"MOSAIC has proven to be an invaluable solution to physicians in markets throughout the world, and we are extremely pleased to have received clearance to market this breakthrough system in the United States," said Shaun Cave, President of Lutronic USA. "This represents an important milestone in the continued growth and evolution of Lutronic USA, and we look forward to continued growth in this market as we strive to deliver a full range of premier quality technologies and solutions to the clinical community."

For additional information on Lutronic USA, visit www.lutronicusa.com or www.lutronic.com

###